Ileana L. Piña, MD, MPH Professor of Medicine & Epidemiology and Population Health Albert Einstein College of Medicine Associate Chief of Academic Affairs Division of Cardiology Staff Heart Failure/Transplant Montefiore Medical Center Bronx, NY
Alan B. Storrow, MD Vice Chairman for Research and Academic Affairs Department of Emergency Medicine Vanderbilt University Nashville, TN
John J. Russell, MD Director of Family Medicine Residency Abington Memorial Hospital Clinical Professor of Family and Community Medicine Temple University School of Medicine Philadelphia, PA
CCME Reviewer Daniel B. Sims, MD Assistant Professor of Medicine Division of Cardiology Director, Moses Cardiac Care Unit Center for Advanced Cardiac Therapy Montefiore Medical Center Albert Einstein College of Medicine Bronx, NY
AMA PRA Category 1 Credit TM Medium
Diagnosis of AHF is often delayed because of the complex characteristics of the condition. The heterogeneous nature of AHF patients and the presence of comorbid conditions can make it difficult for clinicians to recognize the signs of AHF and provide optimal treatment. A paucity of data on AHF and a lack of agreement regarding the parameters of the disease state exacerbate this challenge. This interactive newsletter will outline strategies for optimal diagnosis and management of this disease.
This activity is jointly provided by Albert Einstein College of Medicine and Montefiore Medical Center, and MCM Education.
This educational activity is intended for cardiologists, hospitalists, emergency medicine and primary care clinicians and other healthcare providers involved in the treatment and management of patients with AHF.
Upon completion of this educational activity, the participant should be able to:
Discuss potential new definitions of AHF that more accurately describe this condition.
Recall current scientific evidence supporting standard treatments for AHF.
The “Conflict of Interest Disclosure Policies” of Albert Einstein College of Medicine of Yeshiva University require that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.
The Albert Einstein College of Medicine of Yeshiva University (Einstein) also require that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.
Contributors whose COIs are irresolvable are not permitted to participate in Einstein CME activities.
Ileana L. Piña, MD, MPH, has no financial conflicts to disclose.
Alan B. Storrow, MD, discloses that he has served as a consultant for the following: Beckman Coulter, Novartis, Alere Diagnostics, Trevena.
John J. Russell, MD, discloses that he has served on the speakers bureau for SanofiPasteur and as a consultant for Takeda and Valeant Pharmaceuticals.
The staff of CCME of Albert Einstein College of Medicine have no disclosures to report with any commercial interests relative to this CME activity.
Daniel B. Sims, MD, has no financial conflicts to disclose.
Lily McVey (MCM Education, medical writer) has no financial conflicts to disclose.
Kathleen Hines (MCM Education, editorial director) has no financial conflicts to disclose. Credit Statements
ACCME ACCREDITATION STATEMENT: This activity has been planned and implemented in accordance with the requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint providership of Albert Einstein College of Medicine of Yeshiva University, Montefiore Medical Center, and MCM Education. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
ACCME CREDIT DESIGNATION STATEMENT: Albert Einstein College of Medicine of Yeshiva University designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support Statements
Supported by an independent educational grant from Novartis.
There are no fees for participating in or receiving credit for this online educational activity.
Participants must review the activity the activity in its entirety, successfully complete the post-test, and submit an evaluation to receive continuing education credit. Credit will be awarded for a post-test score of 80% or better, and a statement may be printed immediately after passing the post-test online.
Please turn off all pop-up blockers to ensure access to the educational activity.
Click on the "Start program" icon at the bottom of this page. If you are not already registered as a user of this website, this will bring you to the login/registration page where you will be able to register as a new CMEcorner.com member or review your existing registration information. When ready, click on the "Continue to Program" icon at the bottom of the screen. Alternatively, click on "Start as Guest."
The activity will take approximately 30 minutes to complete.
After the activity has finished, click on the "Post-test" button.
Instructions for completing and submitting the post-test and evaluation are provided on the post-test screen.
Presented by Albert Einstein College of Medicine & Montefiore Medical Center, Center for Continuing Medical Education, and MCM Education.
The opinions expressed in these educational activities are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, Albert Einstein College of Medicine & Montefiore Medical Center, Center for Continuing Medical Education, or Novartis. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.